Secure and highly productive vaccines are available for two viral STIs: hepatitis B and HPV. These vaccines have represented significant advancements in STI prevention. By the end of 2023, the HPV vaccine had been introduced as Component of regimen immunization programmes in 140countries, mainly significant- and Center-revenue international locations. These https://us.hc6.org/